Profil
Thomas Langenickel is Chief Medical & Development Officer at Gubra A since 2026.
Formerly, Dr. Langenickel was Chief Medical Officer at ETHRIS GmbH.
Dr. Langenickel earned a doctorate from Humboldt-Universität zu Berlin.
Postes actifs de Thomas Langenickel
| Sociétés | Poste | Début |
|---|---|---|
| GUBRA A/S | Directeur Technique/Scientifique/R&D | 05/01/2026 |
Anciens postes connus de Thomas Langenickel
| Sociétés | Poste | Fin |
|---|---|---|
ETHRIS GmbH
ETHRIS GmbH BiotechnologyHealth Technology Develop therapeutics for the treatment of asthma and rare pulmonary diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Thomas Langenickel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Humboldt-Universität zu Berlin
Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
ETHRIS GmbH
ETHRIS GmbH BiotechnologyHealth Technology Develop therapeutics for the treatment of asthma and rare pulmonary diseases | Health Technology |
















